Assessment of risk factors associated with HTLV-1/-2 infection among people living with HIV/AIDS in Bauchi State, Nigeria

References

• Galetto LR, Lunge VR, Béria JU, et al. Prevalence and risk factors for human T cell lymphotropic virus infection in southern Brazilian HIV-positive patients. AIDS Res Hum Retroviruses. 2014;30(9):907–911.
   PubMed Web of Science ®Google Scholar
• Ribeiro MP, Gonçales JP, de Morais VMS, et al. HTLV 1/2 prevalence and risk factors in individuals with HIV/AIDS in Pernambuco, Brazil. J Braz Soc Trop Med. 2019;52:e20180244.
   Web of Science ®Google Scholar
• Beilke MA. Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research. AIDS Res Hum Retroviruses. 2012;28(2):139–147.
   Web of Science ®Google Scholar
• Meidani M, Ahmadi N, Jamali B, et al. Relative frequency of human T-cell lymphotropic virus I/II in HIV/AIDS patients. Adv Biomed Res. 2014;3:8.
   PubMedGoogle Scholar
• Mazanderani AFH, Ebrahim O. Progressive HIV–1 infection in the presence of a raised CD4+count: HIV– 1/HTLV–1 co–infection. South Afr J HIV Med. 2013;14(2):92–94.
   Web of Science ®Google Scholar
• Adeoye OA, Ashaka OS, Omoare AA, et al. Sero-prevalence of human T-lymphotrophic virus 1/2 among HIV-1 infected individuals in Ilorin, Nigeria. Afr J Clin Exper Microbiol. 2019;20(3):202–208.
   Google Scholar
• Hananiya HS, Ella EE, Aminu M, et al. Prevalence of human T-cell lymphotropic virus and the socio-demographic and risk factors associated with the infection among post-natal clinics women in Zaria, Nigeria. J Immunoassay Immunochem. 2019;40(3):1–10.
   Google Scholar
• Okoye AE, Begbulam OG, Onoh RC. Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria. J Blood Med. 2015;6:31–36.
   Web of Science ®Google Scholar
• Paiva AM, Assone T, Haziot MEJ, et al. Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring. Sci Rep. 2018;8:7742.
   PubMed Web of Science ®Google Scholar
• de Aguiar AS, França SAA, Santana BB, et al. Human T-lymphotropic virus 1aA circulation and risk factors for sexually transmitted infections in an Amazon geographic area with lowest human development index (Marajó Island, Northern Brazil). BMC Infect Dis. 2017;17:758.
   Web of Science ®Google Scholar
• Nasir IA, Ahmad EA, Emeribe AU, et al. Molecular detection and clinical implications of HTLV–1 infections among antiretroviral therapy– Naïve HIV–1–1–infected individuals in Abuja, Nigeria. Virol (Auckl). 2015;6:17–23.
   PubMedGoogle Scholar
• Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.
   PubMed Web of Science ®Google Scholar
• Romanelli LF, Caramelli P, Carneiro-Proietti AB. Human T-cell lymphotrophic virus type 1 (HTLV-1): when to suspect infection? Revista Da Associacao Medica Brasileira. 2010;56(3):340–347.
   Google Scholar
• Rego FFA, Alcantara LCJ, de Oliveira T. Human T cell lymphotrophic virus type 1 (HTLV) infection increases the CD4 count in human immunodeficiency virus type 1 (HIV–1) infected patients submitted to antiretroviral therapy (ART). Retrovirol. 2014;11(S1):62.
   Google Scholar
• Holmgren B, Da Silva Z, Larsen O, et al. Dual infections with HIV–1, HIV–2 and HTLV–I are more common in older women than men in Guinea–Bissau. AIDS. 2003;17(2):241–253.
   Web of Science ®Google Scholar
• Ministério da Saúde (MS). Departamento de Vigilância e Controle das IST, do HIV/AIDS e das Hepatites Virais. Protocolo Clínicoe Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos. Brasília: MS; 2013 [cited 2019 Aug 16]; 416 p. Disponível em: http://www.aids.gov.br/pt-br/pub/2013/protocolo-clinico-e-diretrizes-terapeuticaspara- manejo-da-infeccao-pelo-hiv-em-adultos
   Google Scholar
• Jõgeda EL, Avi R, Pauskar M, et al. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infect Genet Evol. 2016;43:83–85.
   Web of Science ®Google Scholar
• Brodish P, Singh K, Rinyuri A, et al. Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE Study. Drug Alcohol Depend. 2012;119(1–2):138–141.
   Web of Science ®Google Scholar
• Ehrlich GD, Glaser JB, Lavigne K, et al. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood. 2011;74(5):1658–1664.
   Google Scholar
• McIntyre PG, Hill DA, Appleyard K, et al. Prevalence of antibodies to hepatitis C virus, HIV and human T-cell leukaemia/lymphoma viruses in injecting drug users in Tayside, Scotland, 1993-7. Epidemiol Infect. 2001;126(1):97–101.
   Web of Science ®Google Scholar
• Malm K, Hillgren K, Britton S, et al. HTLV-2 infection still prevalent among older injecting drug users in Stockholm, Sweden - indications of limited spread to the younger generation. Retrovirology (Auckl). 2011;8(1):A67.
   Google Scholar